These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis. Steinbrecher UP; Kovacs TO; Gelly A; Tourigny M Clin Invest Med; 1983; 6(4):327-30. PubMed ID: 6671363 [TBL] [Abstract][Full Text] [Related]
9. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors. N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203 [No Abstract] [Full Text] [Related]
10. Study of serum alanine-aminotransferase levels in blood donors in Spain. Lozano M; Cid J; Bedini JL; Mazzara R; Gimenez N; Mas E; Ballesta A; Ordinas A Haematologica; 1998 Mar; 83(3):237-9. PubMed ID: 9573678 [TBL] [Abstract][Full Text] [Related]
11. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter? Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857 [No Abstract] [Full Text] [Related]
12. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis. Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437 [TBL] [Abstract][Full Text] [Related]
13. Measurement of alanine aminotransferase (ALT) levels in Zimbabwean donor serum--a possible indicator of non-A, non-B hepatitis. Emmanuel JC; Bassett MT; Smith HJ; Paterson LE Cent Afr J Med; 1989 Aug; 35(8):469-70. PubMed ID: 2509075 [No Abstract] [Full Text] [Related]
14. [Sex and age specific GPT limit values in blood donors]. Caspari G; Beyer J; Gerlich WH; Schmitt H Beitr Infusionsther; 1992; 30():53-6. PubMed ID: 1284766 [TBL] [Abstract][Full Text] [Related]
16. Monophasic and polyphasic pattern of alanine aminotransferase in acute non-A, non-B hepatitis. Clinical and prognostic implications. Pastore G; Monno L; Santantonio T; Angarano G; Trotta F; Schiraldi O Hepatogastroenterology; 1985 Aug; 32(4):155-8. PubMed ID: 3932172 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study. Torezan-Filho MA; Alves VA; Neto CA; Fernandes HS; Strauss E Liver Int; 2004 Dec; 24(6):575-81. PubMed ID: 15566507 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases 2 and 9 correlate with alanine aminotransferase and hepatitis C virus in blood donors. Tseng GC; Peng YC; Wang HH; Lee FH; Huang LR Hepatogastroenterology; 2008; 55(82-83):535-8. PubMed ID: 18613403 [TBL] [Abstract][Full Text] [Related]